BNN:XETRA BRAIN Biotech AG

EUR 2.81 -0.05 -1.748252
Icon

BRAIN Biotech AG (BNN:XETRA) Stock Analysis and Price Targets

COMMON STOCK | Specialty Chemicals | XETRA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 2.81

-0.05 (-1.75)%

EUR 0.06B

0.01M

N/A

N/A

Icon

BNN:XETRA

BRAIN Biotech AG (EUR)
COMMON STOCK | XETRA
EUR 2.81
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.06B

N/A

EUR 2.81

BRAIN Biotech AG (BNN:XETRA) Stock Forecast

N/A

Based on the BRAIN Biotech AG stock forecast from 0 analysts, the average analyst target price for BRAIN Biotech AG is not available over the next 12 months. BRAIN Biotech AG’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BRAIN Biotech AG is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, BRAIN Biotech AG’s stock price was EUR 2.81. BRAIN Biotech AG’s stock price has changed by -9.94% over the past week, -26.44% over the past month and -53.01% over the last year.

No recent analyst target price found for BRAIN Biotech AG
No recent average analyst rating found for BRAIN Biotech AG

Company Overview BRAIN Biotech AG

BRAIN Biotech AG engages in the research and development of Bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates in three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes and bi...Read More

Darmstädter Strasse 34-36, Zwingenberg, Germany, 64673

311

September

EUR

Germany

Adjusted Closing Price for BRAIN Biotech AG (BNN:XETRA)

Loading...

Unadjusted Closing Price for BRAIN Biotech AG (BNN:XETRA)

Loading...

Share Trading Volume for BRAIN Biotech AG Shares

Loading...

Compare Performance of BRAIN Biotech AG Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BNN:XETRA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To BRAIN Biotech AG (Sector: Specialty Chemicals )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AIL:XETRA
Air Liquide SA +0.04 (+0.02%) EUR98.15B 31.95 16.16

ETFs Containing BNN

Symbol Name BNN's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About BRAIN Biotech AG (BNN:XETRA) Stock

Stock Target Advisor's fundamental analysis for BRAIN Biotech AG's stock is Bearish.

Unfortunately we do not have enough data on BNN:XETRA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BNN:XETRA's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BNN:XETRA's stock to indicate if its overvalued.

The last closing price of BNN:XETRA's stock was EUR 2.81.

The most recent market capitalization for BNN:XETRA is EUR 0.06B.

Unfortunately we do not have enough analyst data on BNN:XETRA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains BRAIN Biotech AG's stock.

As per our most recent records BRAIN Biotech AG has 311 Employees.

BRAIN Biotech AG's registered address is Darmstädter Strasse 34-36, Zwingenberg, Germany, 64673. You can get more information about it from BRAIN Biotech AG's website at https://www.brain-biotech.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...